Skip to search formSkip to main contentSkip to account menu

ML 236B

Known as: ML 236 B, ML-236B, ML236B 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
ToSHIHIRo HABA, HIROSHI MABUCHI, AKIRA YOSHIMURA,AKIRA WATANABE, TAKANOBUWAKASUGI, RYozo TATAMI, KoSEI UEDA, RYoSEI UEDA, ToMIO… 
1997
1997
La presente invention porte sur un nouveau procede de production de ML-236B, un precurseur de pravastatine sodium, et notamment… 
Review
1991
Review
1991
The attempts to find a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase which catalyzes the rate… 
1987
1987
Using a stepwise selection procedure, we have developed a line of mouse FM3A cells which is resistant to compactin (ML-236B), a… 
1986
1986
Approximately 1,600 fungal strains were tested for ability to convert compactin (ML-236B) to ML-236A and Emericella unguis IFO… 
1985
1985
Several fungal strains were found to convert compactin (ML-236B) to 5'-phosphocompactic acid. The product was isolated by solvent… 
1985
1985
Mouse mammary carcinoma FM3A cells, which are able to grow in a serum-free medium, have novel characteristics that could be… 
1983
1983
Three actinomycetes having capability of 3 beta-hydroxylation of ML-236B were isolated from soil samples collected in Australia… 
1983
1983
ML-236B is a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the key regulatory enzyme in the… 
1981
1981
Effects of vitamin B2-butyrate, nicomol, ML-236B, KF 1492 and pantethine, which are hypolipidemic drugs, on biochemical values…